Study Details
A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Clinicaltrials.gov ID
Astellas Study ID
1941-CL-9001
EudraCT ID
N/A
Condition
Adult Onset Diabetes
Phase
Phase 3
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
May 2016 - Jun 2017
Masking
Triple (Participant, Care Provider, Investigator)
Enrollment number
268
A Phase 3, Double-blind, Randomized Study to Assess the Efficacy and Safety of Ipragliflozin in Combination with Metformin Compared to Metformin Plus Placebo in Subjects in Russia with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site RU70009
Moscow, Russian Federation, 125315
Site RU70015
Volgograd, Russian Federation, 400001
Site RU70007
St. Petersburg, Russian Federation, 197022
Site RU70011
Moscow, Russian Federation, 117036
Site RU70005
Moscow, Russian Federation, 119034
Site RU70003
Moscow, Russian Federation, 121374
Site RU70002
St. Petersburg, Russian Federation, 197706
Site RU70006
Samara, Russian Federation, 443067
Site RU70001
Yaroslavl, Russian Federation, 150003
Site RU70013
Yaroslavl, Russian Federation, 150062
Site RU70010
Nizhniy Novgorod, Russian Federation, 603018
Site RU70004
Saratov, Russian Federation, 410012
Site RU70014
St. Petersburg, Russian Federation, 194354
Site RU70008
St. Petersburg, Russian Federation, 191119